¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"holy cross"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • maltese cross
    ¸»Å×½º½ÊÀÚÇü
  • testosterone cross-reactivity
    ³²¼ºÈ£¸£¸ó±³Â÷¹ÝÀÀ¼º
  • direct cross matching
    Á÷Á¢±³Â÷½ÃÇè
  • innervated cross finger flap
    ½Å°æÁö¹è¼Õ°¡¶ô±³Â÷ÇÇÆÇ
  • plasma cross matching
    (¢¡cross matching) Ç÷Àå±³Â÷½ÃÇè
  • nerve cross over
    ½Å°æ±³Â÷¼ú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • cross striated muscle fiber
    Ⱦ¹®±Ù¼¶À¯(üôÚ£ÐÉàéë«).
  • cross striated muscular tissue
    Ⱦ¹®±ÙÁ¶Á÷(¡­ðÚòÄ).
  • cross striation
    °¡·Î¹«´Ì, Ⱦ¹®(üôÚ£).
  • cross talk
    ±³Â÷ ´ëÈ­
  • cross tolerance
    ±³Â÷³»¼º(Îßó©Ò±àõ)
  • cross tolerance
    ±³Â÷¸é¿ª°ü¿ë
  • cross training
    ±³Â÷ÈÆ·Ã(ÊÙÌ·Ëç).
  • cross-cultural psychiatry
    Ⱦ¹®È­Á¤½ÅÀÇÇÐ(üôÙþûùïñãêì¢ùÊ)(°úÇÐ)
  • cross-dressing
    À̼ºº¹Àå(ì¶àõÜ×íû)
  • cross-eye
    ³»»ç½Ã(ÞØãÊ)
  • cross-fire treatment
    ±³»ç¿ä¹ý(ÎßÞÒèþÛö).
  • cross-linking
    ±³Â÷°áÇÕ
  • cross-linking theory
    ±³Â÷¿¬°üÀÌ·Ð(Îßó©ææÎ¼ìµÖå)
  • cross-match
    ±³Â÷ÀûÇÕ.
  • cross-matching
    ±³Â÷ÀûÇÕ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CSA Canadian Standards Association; canavaninosuccinic acid; carbonyl salicylamide; cell surface antigen...
CSE clinical-symptom/self-evaluation [questionnaire]; cone-shaped epiphysis; conventional spin-echo; cro...
DCLHb diaspirin cross-linked hemoglobin
FCXM flow cytometric cross-matching
ICRC infant care review committee; International Committee of the Red Cross
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CREG cross reactive group
CRM cross reactive material
ISCs inter-strand cross-links
MCA minimum cross-sectional area
SICRI substance immunologically cross reactive with insulin
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Roman cross
    ·Î¸¶ ½ÊÀÚ
  • Southern Cross,the
    ³²½ÊÀÚ¼º
  • cross
    (2¼±ÀÌ)±³Â÷ÇÏ´Ù;(±æ.°­À»)°Ç³Ê°¡´Ù;(...¿¡¼­...À¸·Î)°Ç³Ê´Ù;µµÇ×ÇÏ´Ù;(µÎ »ç¶÷ÀÌ)½ºÃÄÁö³ª°¡´Ù;(µÎÀåÀÇ ÆíÁö µîÀÌ)¾ù°¥¸®´Ù;(µ¿½Ä¹°ÀÌ)±³¹èÇÏ´Ù;ÀâÁ¾ÀÌ µÇ´Ù;±³Â÷ÇÑ;°¡·ÎÀÇ;ºñ½ºµëÇÑ;°¡·ÎÁö¸¥;...¿Í ¾ù°¥¸°;...¿¡ ¹Ý´ëµÇ´Â;¹è¹ÝÇÏ´Â;¹Ý´ëÀÇ;°Å²Ù·ÎÀÇ;¿ªÀÇ;ºÒ¸®ÇÑ;ºÒÆíÇÑ;½Ã
  • cross
    ½ÊÀÚÇü;½ÊÀÚ°¡;±×¸®½ºµµ°¡ ¸ø¹ÚÈù ½ÊÀÚ°¡;±×¸®½ºµµÀÇ ¼ö³­;¼ÓÁË;±×¸®½ºµµÀÇ ¼ö³­»ó(µµ);(½ÊÀÚ°¡·Î »ó¡µÇ´Â)±âµ¶±³(±¹°¡)(Christianity,Christendo m);¼ö³­;½Ã·Ã;°í³­(affliction);°í»ý(°Å¸®);ºÒÇà;Àå¾Ö;½ÊÀÚ²Ã;½ÊÀÚ ±âÈ£;xÇ¥(¹®¸ÍÀÚÀÇ ¼­¸íÀÇ ´ë¿ë);(¸Í¼¼.ÃູµîÀ» ÇÒ¶§ °ø
  • cross
    ÀâÁ¾(mongrel);ÀýÃæ;Áß°£¹°;ºÎÁ¤;±â¸¸;¾ß¹ÙÀ§;(½ÊÀÚÇüÀÇ Á¾·ù);±³Â÷½ÃŰ´Ù;¾ù°É´Ù;(¼­·Î)±³Â÷ÇÏ´Ù;½ÊÀÚ(¼ºÈ£)¸¦ ±ß´Ù;°¡·ÎÁÙÀ» ±ß´Ù;(¼öÇ¥¿¡)Ⱦ¼±À» ±ß´Ù;¸»»ìÇÏ´Ù;(¾´ ÆíÁö À§¿¡)´Ù½Ã ±³Â÷ÀûÀ¸·Î ½á³Ö´Ù(¿ìÆí ¿ä±ÝÀ» ¾Æ³¢±â À§ÇÏ¿©);(±æ.»ç¸· µîÀ»)°¡·ÎÁö¸£´Ù;Ⱦ´ÜÇÏ´Ù;³Ñ´Ù
  • cross action
    ¹Ý´ë ¼Ò¼Û;¹Ý¼Ò
  • cross bun
    ½ÊÀÚ ¹«´Ì·Î ´çÀǸ¦ ÀÔÈù °úÀÚ »§
  • cross counter
    Å©·Î½ºÄ«¿îÅÍ(»ó´ë¹æ °ø°Ý¿¡ ´ëÇØ ±³Â÷ÀûÀ¸·Î °¡ÇÏ´Â ¹Ý°Ý)
  • cross current
    ¿ª·ù;´ë¸³ÇÏ´Â °æÇâ
  • cross cut
    °¡·Î ÄÑ´Â (Åé);°¡·Î ÀÚ¸¥;»û±æ;Áö¸§±æ;(Àç¸ñÀÇ)°¡·ÎÄѱâ;ȰÁÖÇüÀÇ ÀÏÁ¾(½ºÄÉÀÌÆ®);°¡·ÎÄÑ´Ù;°¡·ÎÁö¸£´Ù;~ter
  • cross fire
    ½ÊÀÚÆ÷È­;(Áú¹®ÀÇ)ÀÏÁ¦ °ø¼¼;(¸»ÀÇ)°Ý·ÄÇÑ ÀÀ¼ö;Ç÷¹ÀÌÆ®ÀÇ °¢À» ÁÇ·Î °¡·ÎÁö¸£´Â Åõ±¸
  • cross grain
    ¾ù°á
  • cross hairs
    (¸Á¿ø°æ µîÀÇ ÃÐÁ¡¿¡ »ý±ä)½ÊÀÚ¼±
  • cross keys
    2 °³ÀÇ ¿­¼è°¡ ±³Â÷ÇÑ ¹®Àå(·Î¸¶ ±³È²ÀÇ)
  • cross license
    »óÈ£ ƯÇã »ç¿ë Çã°¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á